GeneBio and Swiss Institute of Bioinformatics Release new Version of Melanie 2-D Gel Analysis Platform

Geneva Bioinformatics (GeneBio) SA and the Swiss Institute of Bioinformatics (SIB) have announced the release of a new version of the renowned Melanie 2-D gel analysis platform.

Version 7.0 of Melanie is designed to offer an entirely revised user interface and user interaction modes that can streamline the analysis process, resulting in major usability that can facilitate the completion of both simple and complex tasks as well as high throughput analysis.

According to GeneBio, Melanie is developed by the SIB and GeneBio in collaboration with GE Healthcare and is a recognized leader in the field of two-dimensional gel electrophoresis analysis strengthened by an active 20-year presence in the market. It offers a flexible interface for visualization, exploration and analysis of 2-D gel data from both DIGE (Fluorescence Difference Gel Electrophoresis) and non-DIGE technologies.

The company claims, this version of Melanie improves the way researchers analyze their 2-D electrophoresis gels to identify protein markers of interest. It avoids inaccuracies due to manual spot editing and minimizes repetitive match editing tasks. It helps reduce time spent finding significant protein expression changes and increases the reliability of the result.

GeneBio will demonstrate this latest release at the upcoming ABRF meeting in February (booth no. 219).